• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

The clinical implications of hypertension in addition to a high prevalence of both
uncontrolled blood pressure and medication nonadherence promote interest in developing …

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

More than 1.5 billion people worldwide have arterial hypertension. Hypertension increases
the risks of death and cardiovascular disease, such as atrial fibrillation and heart failure. The …

Resistant hypertension is defined as blood pressure that remains above the therapeutic goal
despite concurrent use of at least three antihypertensive agents of different classes …

Hypertension is the major risk factor for cardiovascular morbidity and mortality. Matter of fact,
untreated hypertension can worsen the overall health, whereas pharmacotherapy can play …

Arterial hypertension is the most important mod-ifiable risk factor for cardiovascular morbidity
and mortality. 1 Safe and effective antihypertensive drugs are widely available but the …

For years, hypertension (HT) has remained one of the most common risk factors leading to
cardiovascular disease (CVD) and death both in Poland and worldwide [1–5]. Therefore, its …

Hypertension is the most prevalent modifiable risk factor associated with cardiovascular
mortality. The World Health Organization (WHO) estimates that hypertension directly or …